SuperworthCullinan Therapeutics shares outstanding CGEM
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Sep 30, 2024
- 58.3M
- On a year earlier
- +36.5%
- more shares
Cullinan Therapeutics had 58.3M diluted shares outstanding on average in Q3 FY24, the quarter to Sep 30, 2024.
That is 36.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 42.8M | −6% |
| FY2022 | 45.8M | +8% |
| FY2021 | 42.6M | +101% |
| FY2020 | 21.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY24 | 58.3M | +37% | |
| Q2 FY24 | 55.1M | +38% | |
| Q1 FY24 | 43M | +6% | |
| Q4 FY23 | 42.8M | −6% | |
| Q3 FY23 | 42.7M | −6% | |
| Q2 FY23 | 40M | −14% | |
| Q1 FY23 | 40.7M | −8% | |
| Q4 FY22 | 45.8M | +8% | |
| Q3 FY22 | 45.6M | +5% | |
| Q2 FY22 | 46.4M | +7% | |
| Q1 FY22 | 44.4M | +6% | |
| Q4 FY21 | 42.6M | +101% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cullinan Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.